Type 2 Diabetes Trial, Recruiting (NCT02836808)

Type 2 Diabetes Trial, Recruiting NCT02836808 Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT02836808 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 70 years old
You have been diagnosed with type 2 diabetes within the last five years
You have family support available to you
You do not have serious or disabling complications from diabetes

Who may not be able to join:

You have advanced diabetes-related complications, such as heart disease, severe heart failure, significant kidney disease, amputations, brain blood vessel disease, stomach nerve damage, or muscle wasting (confirm with trial site)
You have type 1 diabetes, diabetes related to pregnancy, or a rare form of diabetes linked to a genetic condition or that is very difficult to control
You have another serious illness, such as cancer, that may affect how long you are expected to live
You have significant memory or thinking problems, or a serious mental health condition
You currently smoke, or have problems with alcohol or illegal drug use
You need surgery in the near future, or have a condition that prevents you from doing light to moderate physical activity

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sergio C Hernández, MD, National Institute of Medical Sciences and Nutrition Salvador Zubirán

Phone: 57870900

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02836808

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 57870900

More information: https://clinicaltrials.gov/study/NCT02836808

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 70 years old
You have been diagnosed with type 2 diabetes within the last five years
You have family support available to you
You do not have serious or disabling complications from diabetes

Who may not be able to join:

You have advanced diabetes-related complications, such as heart disease, severe heart failure, significant kidney disease, amputations, brain blood vessel disease, stomach nerve damage, or muscle wasting (confirm with trial site)
You have type 1 diabetes, diabetes related to pregnancy, or a rare form of diabetes linked to a genetic condition or that is very difficult to control
You have another serious illness, such as cancer, that may affect how long you are expected to live
You have significant memory or thinking problems, or a serious mental health condition
You currently smoke, or have problems with alcohol or illegal drug use
You need surgery in the near future, or have a condition that prevents you from doing light to moderate physical activity

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Registry

ClinicalTrials.gov

Start date

31 October 2013

Est. completion

9 February 2018

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Diabetes control after 4 visits in a structured multidisciplinary program for patients with diabetes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov